Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efeee197d0504b55aee9505009037a71 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2009-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44e91c6979a0f86fd004ab82a4f85a0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbbea3e283d93861df7bcca3c14d41b8 |
publicationDate |
2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010241783-A |
titleOfInvention |
Anti-ATBF1 antibody and use thereof |
abstract |
An object of the present invention is to provide an anti-ATBF1 antibody excellent in sensitivity and specificity and to provide a use thereof. A monoclonal antibody that recognizes full-length human ATBF1 (AT motif binding factor 1) is provided. The malignancy of the test cancer cell is determined using the antibody. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012240942-A |
priorityDate |
2009-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |